SCHEMBL22177216

SCHEMBL22177216

c1ccc(-c2nc(-c3ccc4c(c3)oc3ccccc34)nc(-c3cccc4oc5ccc(-c6ccc(-c7nc8ccccc8s7)cc6)cc5c34)n2)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 9/20 0.42
▸ ALDH1A1 P00352 3/20 0.42
▸ POLB P06746 2/20 0.42
▸ HPGD P15428 2/20 0.42
▸ CTDSP1 Q9GZU7 1/20 0.42
▸ THRB P10828 2/20 0.41
▸ APP P05067 3/20 0.40
▸ MMP9 P14780 2/20 0.40
▸ MMP8 P22894 2/20 0.40
▸ MEN1 O00255 2/20 0.39
▸ KMT2A Q03164 2/20 0.39
▸ NPSR1 Q6W5P4 1/20 0.39
▸ RAB9A P51151 6/20 0.38
▸ NFKB1 P19838 3/20 0.38
▸ NFKB2 Q00653 3/20 0.38
▸ RELA Q04206 3/20 0.38
▸ KDM4E B2RXH2 3/20 0.38
▸ NPC1 O15118 3/20 0.38
▸ SMN1; SMN2 Q16637 3/20 0.38
▸ LMNA P02545 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22177351 0.97 MAPT (0.42) MAPTALDH1A1POLBHPGDCTDSP1
SCHEMBL22177895 0.96 MAPT (0.42) MAPTALDH1A1POLBHPGDCTDSP1
SCHEMBL22177211 0.96 MAPT (0.44) MAPTALDH1A1POLBHPGDCTDSP1
SCHEMBL22177350 0.96 MAPT (0.44) MAPTALDH1A1POLBHPGDCTDSP1
SCHEMBL22177422 0.96 MAPT (0.44) MAPTALDH1A1POLBHPGDCTDSP1
SCHEMBL22177478 0.95 MAPT (0.44) MAPTALDH1A1POLBHPGDCTDSP1
SCHEMBL22177347 0.95 MAPT (0.44) MAPTALDH1A1POLBHPGDCTDSP1
SCHEMBL22178378 0.95 APP (0.44) MAPTALDH1A1POLBHPGDCTDSP1
SCHEMBL22178375 0.95 APP (0.44) MAPTALDH1A1POLBHPGDCTDSP1
SCHEMBL22178190 0.93 APP (0.44) MAPTALDH1A1POLBHPGDCTDSP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11518769-B2 Heterocyclic compounds and organic light emitting device using the same LG CHEM, LTD. (KR) 2022-12-06 — — US disclosed
US-20200207754-A1 NOVEL HETEROCYCLIC COMPOUNDS AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME LG CHEM, LTD. (KR) 2020-07-02 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200207754-A1 NOVEL HETEROCYCLIC COMPOUNDS AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME CRY1, CRY2, CYP1A1 MAPT 1997/4885ALDH1A1 18/4885POLB 2562/4885
US-11518769-B2 Heterocyclic compounds and organic light emitting device using the same CRY1, CYP1A1, CRY2 MAPT 1660/4885ALDH1A1 16/4885POLB 2025/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback